Standard Biotools (LAB) Depreciation & Amortization (CF) (2021 - 2026)

Standard Biotools (LAB) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $1.4 million in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 33.33% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $6.2 million, a 26.53% increase from a year earlier, with the FY2025 full-year figure at $6.9 million, up 81.58% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.4 million, up from $1.3 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for LAB reached as high as $3.0 million in Q1 2024 and fell as low as $700000.0 in Q1 2023.
• Historically, Depreciation & Amortization (CF) has averaged $1.6 million across 5 years, with a median of $1.4 million in 2026.
• Across the five-year window, Depreciation & Amortization (CF) tumbled 68.69% in 2022 and soared 328.57% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $2.8 million in 2022, then slumped by 75.0% to $700000.0 in 2023, then gained by 14.29% to $800000.0 in 2024, then soared by 62.5% to $1.3 million in 2025, then advanced by 7.69% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.4 million in Q1 2026, $1.3 million in Q4 2025, and $1.5 million in Q3 2025.